Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma

Abstract Objective Our study was to investigate the impact of taurolactone, a novel anti-tumor and anti-angiogenic drug, on AGGF1, an angiogenic factor, and angiogenesis mimicry in patients diagnosed with hepatocellular carcinoma (HCC). Methods A total of 120 HCC patients were enrolled from the Depa...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Shaoping Liu, Yinzhi Wei, Lei Nie, Ze Tang, Qi Lu, Qun Liang
Format:	Article
Language:	English
Published:	BMC 2024-05-01
Subjects:	Taurolactone Hepatocellular carcinoma Angiogenic factor AGGF1 Angiogenesis mimicry
Online Access:	https://doi.org/10.1186/s12885-024-12356-w